Table 6.

Risk factors for mortality of renal transplant recipients with mucormycosis

Variable	OR (95% CI)	P
Extent of infection
Localized	Reference
Disseminated	5.41(2.04–14.37)	0.001
Organism
Rhizopus spp.	Reference
Other organisms		>0.1
Diabetes
No	Reference
Diabetes	0.43(0.20–0.89)	0.02
Antifungal therapy
None	Reference
Amphotericin B deoxycholate	0.30 (0.09–0.97)	0.04
Lipid amphotericin B	0.10(0.03–0.33)	<0.001
Posaconazole alone and combined with other antifungals	0.02(0.00–0.22)	<0.01
Surgery
Surgery as primary therapy	Reference
Without surgery therapy	5.83(2.68–12.70)	<0.001